Literature DB >> 24602843

End of the debate about antiretroviral treatment initiation.

Seonaid Nolan1, Evan Wood2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24602843      PMCID： PMC4084688          DOI： 10.1016/S1473-3099(13)70329-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  13 in total

Review 1.  HIV prevention before HAART in sub-Saharan Africa.

Authors:  Elliot Marseille; Paul B Hofmann; James G Kahn
Journal:  Lancet       Date:  2002-05-25       Impact factor: 79.321

2.  Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.

Authors:  Beatriz Grinsztejn; Mina C Hosseinipour; Heather J Ribaudo; Susan Swindells; Joseph Eron; Ying Q Chen; Lei Wang; San-San Ou; Maija Anderson; Marybeth McCauley; Theresa Gamble; Nagalingeshwaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Jose H S Pilotto; Sheela V Godbole; Suwat Chariyalertsak; Marineide Gonçalves de Melo; Kenneth H Mayer; Susan H Eshleman; Estelle Piwowar-Manning; Joseph Makhema; Lisa A Mills; Ravindre Panchia; Ian Sanne; Joel Gallant; Irving Hoffman; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Diane Havlir; Myron S Cohen
Journal:  Lancet Infect Dis       Date:  2014-03-04       Impact factor: 25.071

Review 3.  When to initiate antiretroviral therapy in HIV-1-infected adults: a review for clinicians and patients.

Authors:  Evan Wood; Robert S Hogg; P Richard Harrigan; Julio S G Montaner
Journal:  Lancet Infect Dis       Date:  2005-07       Impact factor: 25.071

4.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

5.  Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda.

Authors:  Elvin H Geng; Mwebesa B Bwana; Winnie Muyindike; David V Glidden; David R Bangsberg; Torsten B Neilands; Ingrid Bernheimer; Nicolas Musinguzi; Constantin T Yiannoutsos; Jeffrey N Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

6.  HIV transmission risk behavior among HIV-infected adults in Uganda: results of a nationally representative survey.

Authors:  Rebecca Bunnell; Alex Opio; Joshua Musinguzi; Wilford Kirungi; Paul Ekwaru; Vinod Mishra; Wolfgang Hladik; Jessica Kafuko; Elizabeth Madraa; Jonathan Mermin
Journal:  AIDS       Date:  2008-03-12       Impact factor: 4.177

7.  Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.

Authors:  J W Mellors; C R Rinaldo; P Gupta; R M White; J A Todd; L A Kingsley
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

8.  Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance.

Authors:  Ajay K Sethi; David D Celentano; Stephen J Gange; Richard D Moore; Joel E Gallant
Journal:  Clin Infect Dis       Date:  2003-09-19       Impact factor: 9.079

Review 9.  Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?

Authors:  Myron S Cohen; M Kumi Smith; Kathryn E Muessig; Timothy B Hallett; Kimberly A Powers; Angela D Kashuba
Journal:  Lancet       Date:  2013-10-23       Impact factor: 79.321

Review 10.  Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis.

Authors:  Ingrid T Katz; Annemarie E Ryu; Afiachukwu G Onuegbu; Christina Psaros; Sheri D Weiser; David R Bangsberg; Alexander C Tsai
Journal:  J Int AIDS Soc       Date:  2013-11-13       Impact factor: 5.396
View more
  8 in total

1.  Antiretroviral treatment initiation--authors' reply.

Authors:  Seonaid Nolan; Evan Wood; Julio S G Montaner
Journal:  Lancet Infect Dis       Date:  2014-11-17       Impact factor: 25.071

2.  'Not Until I'm Absolutely Half-Dead and Have To:' Accounting for Non-Use of Antiretroviral Therapy in Semi-Structured Interviews with People Living with HIV in Australia.

Authors:  Christy E Newman; Limin Mao; Asha Persson; Martin Holt; Sean Slavin; Michael R Kidd; Jeffrey J Post; Edwina Wright; John de Wit
Journal:  AIDS Patient Care STDS       Date:  2015-03-25       Impact factor: 5.078

3.  Maximizing the benefits of antiretroviral therapy for key affected populations.

Authors:  Ian R Grubb; Sarah W Beckham; Michel Kazatchkine; Ruth M Thomas; Eliot R Albers; Mauro Cabral; Joep Lange; Stefano Vella; Manoj Kurian; Chris Beyrer
Journal:  J Int AIDS Soc       Date:  2014-07-18       Impact factor: 5.396

4.  Reassessment of HIV-1 acute phase infectivity: accounting for heterogeneity and study design with simulated cohorts.

Authors:  Steve E Bellan; Jonathan Dushoff; Alison P Galvani; Lauren Ancel Meyers
Journal:  PLoS Med       Date:  2015-03-17       Impact factor: 11.069

5.  Clinic Attendance for Antiretroviral Pills Pick-Up among HIV-Positive People in Nepal: Roles of Perceived Family Support and Associated Factors.

Authors:  Rakesh Ayer; Kimiyo Kikuchi; Mamata Ghimire; Akira Shibanuma; Madhab Raj Pant; Krishna C Poudel; Masamine Jimba
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

6.  Measuring self-reported HIV status in bio-behavioural surveys.

Authors:  Lisa G Johnston; Willi McFarland; Miriam Lewis Sabin; Dimitri Prybylski; Keith Sabin; Stefan Baral; Andrea A Kim; H Fisher Raymond
Journal:  Bull World Health Organ       Date:  2015-05-01       Impact factor: 9.408

7.  The importance of assessing self-reported HIV status in bio-behavioural surveys.

Authors:  Lisa G Johnston; Miriam Lewis Sabin; Dimitri Prybylski; Keith Sabin; Willi McFarland; Stefan Baral; Andrea A Kim; H Fisher Raymond
Journal:  Bull World Health Organ       Date:  2016-04-25       Impact factor: 9.408

8.  Implementation challenges and opportunities for HIV Treatment as Prevention (TasP) among young men in Vancouver, Canada: a qualitative study.

Authors:  Rod Knight; Will Small; Kim Thomson; Mark Gilbert; Jean Shoveller
Journal:  BMC Public Health       Date:  2016-03-15       Impact factor: 3.295
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.